Mainline Biosciences

Private

Malvern, PennsylvaniaHealthcare & Life Scienceshttps://www.mainlinebiosciences.com/

Last Round

VC Round

Jul 1, 2024

Company Overview

Mainline Biosciences is a biotechnology company that specializes in the research and development of novel peptide-based therapeutics and peptide drug conjugates for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

peptide-drug conjugatesPDCpeptide therapeuticsoncology drug discoverytargeted cancer therapydrug discovery platformAI drug discoverycomputational chemistrysolid tumor treatmentbiotech licensingCXCR4 antagonistSSTR2 targetingprecision medicinein silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mainline Biosciences Comparables

Compare Mainline Biosciences with similar companies based on industry and business-model similarity.

Mainline Biosciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Cybrexa Therapeutics	88%
ProteinQure	83%
Nanoligent	77%

View all Comparables

Mainline Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 1, 2024
Series A	Nov 9, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Ning Yang

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 1, 2024
Raised a VC Round with Hangzhou Taikun Equity Investment Fund Partnership.
Nov 9, 2022
Completed a Series A funding round.

View all signals

Mainline Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mainline Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mainline Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMalvern, Pennsylvania

Employee Range4

Year Founded2014

Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?